Linagliptin improves glycemic control in patients with type 2 diabetes independently of the duration of diabetes and insulin resistance

被引：0
|
作者：
Patel, S. [1 ]
Weber, S. [2 ]
Emser, A. [2 ]
von Eynatten, M. [2 ]
Woerle, H. -J [2 ]
Gibelin, B. [3 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[2] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[3] Boehringer Ingelheim GmbH & Co KG, Paris, France
来源：
DIABETES & METABOLISM | 2012年 / 38卷
关键词：
D O I：
10.1016/S1262-3636(12)71387-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A97 / A97
页数：1
相关论文
共 50 条
  • [1] Linagliptin improves glycaemic control independently of diabetes duration and insulin resistance in patients with type 2 diabetes
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S339 - S339
  • [2] LINAGLIPTIN IMPROVES GLYCEMIC CONTROL INDEPENDENT OF BODY MASS INDEX IN PATIENTS WITH TYPE 2 DIABETES
    Rendell, Marc
    Chrysant, Steven
    Trujillo, Angelina
    Emser, Angela
    von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans-Juergen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S214 - S215
  • [3] Linagliptin Monotherapy Improves Glycemic Control and Measures of β-cell Function in Type 2 Diabetes
    Del Prato, Stefano
    Barnett, Anthony
    Huismann, Holger
    Neubacher, Dietmar
    Woerle, Hans-Juergen
    Dugi, Klaus A.
    DIABETES, 2010, 59 : A189 - A189
  • [4] Efficacy and Safety of Linagliptin in Patients with Type 2 Diabetes and Poor Glycemic Control
    Del Prato, Stefano
    Taskinen, Marja-Riitta
    Owens, David
    Von Eynatten, Maximillian
    Emser, Angela
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A293 - A293
  • [5] Early Hospitalization for Diabetes Care Improves Glycemic Control in Patients with Type 2 Diabetes Reserved Insulin Secretion
    Ikeda, Daisuke
    DIABETES, 2018, 67
  • [6] Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus
    Sheu, Wayne H. -H.
    Park, Sung Woo
    Gong, Yan
    Pinnetti, Sabine
    Bhattacharya, Sudipta
    Patel, Sanjay
    Seck, Thomas
    Woerle, Hans-Juergen
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (03) : 503 - 512
  • [7] Pramlintide improves glycemic control in patients with type II diabetes requiring insulin
    Thompson, R
    Pearson, L
    Schoenfeld, S
    Kolterman, O
    DIABETOLOGIA, 1997, 40 : 1397 - 1397
  • [8] Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
    Thomas Rauch
    Ulrike Graefe-Mody
    Carolyn F. Deacon
    Arne Ring
    Jens J. Holst
    Hans-Juergen Woerle
    Klaus A. Dugi
    Tim Heise
    Diabetes Therapy, 2012, 3 (1)
  • [9] Combination of Linagliptin and Metformin Improves Glycemic Control in Type 2 Diabetes: A Randomized Trial with an Open-Label Arm in Patients with Poor Glycemic Control
    Haak, Thomas
    Meinicke, Thomas
    Jones, Russell
    Von Eynatten, Maximilian
    Woerle, Hans J.
    DIABETES, 2011, 60 : A77 - A77
  • [10] Orlistat consistently improves glycemic control in patients with type 2 diabetes
    Hollander, PA
    Van Gaal, L
    DIABETES, 2002, 51 : A472 - A472
12345